Nis Nørgaard

Nis Nørgaard

Auto-generated profile, based on publicly available information

Nis Nørgaard

Department of Urology, Herlev Gentofte University Hospital, Herlev, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2021 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
Michael Bachmann NielsenMichael Bachmann Nielsen
Michael Bachmann Nielsen
SSStinne Byrholdt Søgaard
Stinne Byrholdt Søgaard
SASofie Bech Andersen
Sofie Bech Andersen
BSBjørn Skjoldbye
Bjørn Skjoldbye
KHKristoffer Lindskov Hansen
Kristoffer Lindskov Hansen
Jonathan Frederik CarlsenJonathan Frederik Carlsen
Jonathan Frederik Carlsen
This review looks at highlights of the development in ultrasound, ranging from interventional ultrasound and Doppler to the newest techniques like contrast-enhanced ultrasound and elastography, and gives reference to some of the valuable articles in Acta Radiologica. Ultrasound equipment is now available in any size and for any purpose, ranging from handheld devices to high-end devices, and the scientific societies include ultrasound professionals of all disciplines publishing guidelines and recommendations. Interventional ultrasound is expanding the field of use of ultrasound-guided interventions into nearly all specialties of medicine, from ultrasound guidance in minimally invasive robotic procedures to simple ultrasound-guided punctures performed by general practitioners. Each medical specialty is urged to define minimum requirements for equipment, education, training, and maintenance of skills, also for medical students. The clinical application of contrast-enhanced ultrasound and elastography is a topic often seen in current research settings.

1 April 2017 in Urologia Internationalis
Verified
Journal Article
Open access
LBLars Boesen
Lars Boesen
NNNis Nørgaard
Nis Nørgaard
VLVibeke Berg Logager
Vibeke Berg Logager
IBIngegerd Balslev
Ingegerd Balslev
HTHenrik S. Thomsen
Henrik S. Thomsen
Introduction: The aim of the study was to compare the prostate cancer (PCa) detection rate of systematic transrectal ultrasound-guided biopsies (TRUS-bx) and multiparametric-MRI targeted biopsies (mp-MRI-bx) in a repeat biopsy setting and evaluate the clinical significance following an “MRI-targeted-only” approach. Materials and Methods: Patients with prior negative biopsies underwent prostatic multiparametric-MRI that was scored using the Prostate Imaging Reporting and Data System (PI-RADS) classification. All underwent both repeated TRUS-bx and mp-MRI-bx using image fusion of any PI-RADS ≥3 lesion. Biopsy results from TRUS-bx, mp-MRI-bx, and the combination were compared. Results: PCa was detected in 89 out of 206 (43%) patients. Of these, 64 (31%) and 74 (36%) patients were detected using mp-MRI-bx and TRUS-bx, respectively. Overall, mp-MRI-bx detected fewer patients with low-grade (Gleason score [GS] 3 + 3) cancers (14/64 vs. 41/74) and more patients with intermediate/high-grade cancers (GS ≥3 + 4) (50/64 vs. 33/74) using fewer biopsy cores compared with TRUS-bx (p < 0.001). Using an “MRI-targeted-only” approach in men with PI-RADS ≥3 lesions reduced the number of men requiring repeated biopsies by 50%, decreased low-grade cancer diagnoses by 66%, and increased intermediate/high-grade cancer diagnoses by 52%. Conclusions: MRI-targeted biopsies have a high detection rate for significant PCa in patients with prior negative transrectal ultrasound-guided biopsies and preferentially detect intermediate/high-grade compared with low-grade tumors.

27 February 2012 in Scandinavian Journal of Urology and Nephrology
Verified
Journal Article
Closed access
LKLine Kjær
Line Kjær
MFMikkel Fode
Mikkel Fode
NNNis Nørgaard
Nis Nørgaard
JSJens Sønksen
Jens Sønksen
JNJørgen Nordling
Jørgen Nordling
Objective. This study aimed to evaluate the results of the Danish experience with the ProACT urinary continence device inserted in men with stress urinary incontinence. Material and methods. The ProACT was inserted in 114 patients. Data were registered prospectively. The main endpoints were complications, pad use per day and 24 h urinary leakage. A questionnaire evaluating symptoms and satisfaction was sent to the patients. Results. Data including preoperative and postoperative pad use and urinary leakage were available for 92 and 90 patients, respectively. A decrease in the median 24 h urinary leakage (352.5 vs 11 ml, p < 0.001) and in the median number of pads used per day (4.75 vs 2.25, p = 0.001) was demonstrated. Forty-six patients had a pad use of 0–1 pads per day and/or a daily urinary leakage less than 8 g, corresponding to an overall dry rate of 50%. A decrease in urinary leakage > 50% was seen in 72 patients (80%). Complications were seen in 23 patients. All of these were treated successfully by removal of the device in the outpatient setting followed by replacement of the device. Another eight patients had a third balloon inserted to improve continence further. Fourteen patients (12%) ended up with an artificial sphincter or a urethral sling. Sixty patients (63%) experienced no discomfort and 58 (61%) reported being dry or markedly improved. Overall, 50 patients (53%) reported being very or predominantly satisfied. Conclusions. Adjustable continence balloons seem to be a good alternative in the treatment of male urinary incontinence. Complications are mild and easily treated.

1 December 2017 in Urology
Verified
Journal Article
Closed access
LBLars Boesen
Lars Boesen
NNNis Nørgaard
Nis Nørgaard
VLVibeke Løgager
Vibeke Løgager
IBIngegerd Balslev
Ingegerd Balslev
HTHenrik S. Thomsen
Henrik S. Thomsen

11 August 2014 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
VAValeria Antsupova
Valeria Antsupova
NNNis Nørgaard
Nis Nørgaard
RBRasmus Bisbjerg
Rasmus Bisbjerg
JJJette Nygaard Jensen
Jette Nygaard Jensen
JBJonas Boel
Jonas Boel
MAMagnus Arpi
Magnus Arpi
Fluoroquinolones are extensively used as prophylaxis for transrectal ultrasound-guided biopsy of the prostate (TRUBP). Emerging fluoroquinolone resistance and selection of multiresistant organisms warrant new prophylactic strategies. Pivmecillinam and amoxicillin/clavulanic acid have mutual synergistic activity and the combination of these agents has a broad coverage of the majority of microorganisms causing infectious complications after TRUBP and may be a valuable future prophylactic regimen. This was a retrospective cohort study of 2624 men that underwent TRUBP at a Danish university hospital. The patients were divided into three groups. Group 1 (n = 1220) received ciprofloxacin before TRUBP, Group 2 (n = 240) received a combination of pivmecillinam and amoxicillin/clavulanic acid before TRUBP and Group 3 (n = 1161) received an extended prophylaxis with pivmecillinam and amoxicillin/clavulanic acid before and for 2 days after TRUBP. One hundred and ten out of 148 (74.3%) post-TRUBP infections were caused by Escherichia coli, Klebsiella pneumoniae or Enterococcus faecalis. Group 3 with the extended prophylaxis with pivmecillinam and amoxicillin/clavulanic acid had a significantly lower rate of bacteraemia (0.9%) as compared with Group 1 (1.8%) and Group 2 (3.7%). A significant fall in the proportion of ESBL-producing Enterobacteriaceae was observed from the period when ciprofloxacin was used as prophylaxis (8.1%) compared with the subsequent period when pivmecillinam and amoxicillin/clavulanic acid was used (5.9%). The combination of pivmecillinam and amoxicillin/clavulanic acid is an attractive prophylaxis for TRUBP from a clinical, bacteriological and ecological point of view as compared with ciprofloxacin.

1 November 2011 in European Journal of Radiology
Verified
Journal Article
Closed access
ECElizaveta Chabanova
Elizaveta Chabanova
IBIngegerd Balslev
Ingegerd Balslev
VLVibeke Berg Logager
Vibeke Berg Logager
AHAlastair Hansen
Alastair Hansen
HJHenrik Jakobsen
Henrik Jakobsen
HTHenrik S. Thomsen
Henrik S. Thomsen